| ... disorder ... due to a genetic mutation of chromosome 11 ... carriers might be at an increased risk of certain types of cancer ... very sensitive to radiation ... |
Ataxia - Telangiectasia
Richard A. Gatti , M.D, GeneReviews, February 15, 2005
[for Professionals mainly]
A-T is characterized by progressive cerebellar ataxia beginning between 1 and 3 years of age, choreoathetosis, telangiectasias of the conjunctivae, and increased sensitivity to ionizing radiation followed by immunodeficiency and malignancy, particularly leukemia and lymphoma, in many patients
Analysis of the ATM gene on chromosome 11q22-q23 is available clinically to aid in the diagnosis of symptomatic patients from certain ethnic groups
Known to have a high prevalence of specific ATM mutations
A-T is suspected in young children who have signs of progressive cerebellar dysfunction
slurred speech
oculomotor apraxia
Serum AFP
Elevated above 10 ng/ml in about 90% to 95% of patients
Most patients with A-T in the United States live beyond 20 years of age
The most common misdiagnosis is cerebral palsy
Radiosensitivity is also seen in Nijmegen Breakage syndrome
Carrier testing may be available to relatives of an affected family member either through direct DNA analysis or through linkage analysis
Epidemiological studies suggest that A-T carriers are at an increased risk for cancer, especially breast cancer
Prenatal testing is clinically available and can utilize DNA mutation analysis.
Ataxia - Telangiectasia
John Hopkins University, 2007
[for Professionals mainly]
Gene Map Locus: 11q22.3
AT is an autosomal recessive disorder characterized by cerebellar ataxia, telangiectases, immune defects, and a predisposition to malignancy. Chromosomal breakage is a feature. AT cells are abnormally sensitive to killing by ionizing radiation (IR), and abnormally resistant to inhibition of DNA synthesis by ionizing radiation
4 complementation groups for the classical form of the disease
Clinical Features
Homozygotes
Patients present in early childhood with progressive cerebellar ataxia and later develop conjunctival telangiectases, other progressive neurologic degeneration, sinopulmonary infection, and malignancies. Telangiectases typically develop between 3 and 5 years of age
Ataxia can be misdiagnosed as ataxic cerebral palsy before the appearance of oculocutaneous telangiectases
Gonadal dysfunction in ataxia - telangiectasis was discussed by Miller and Chatten (1967)
The oldest known AT patient
at age 52 years
AT may be the most common syndromic progressive cerebellar ataxia of early childhood. Truncal ataxia precedes appendicular ataxia ... Chromosomal breakage in AT
Leukemia and chromosomal abnormalities occur in at least 2 other mendelian disorders--Fanconi pancytopenia and Bloom syndrome
Lymphomas in AT patients tend to be of B-cell origin
leukemias tend to be of T-CLL type
Other solid tumors, including medulloblastomas and gliomas, occur with increased frequency in AT
Swift et al (1987) examined the cancer risk of heterozygotes for AT in 128 families, including 4 of Amish ancestry, 110 white non-Amish families, and 14 black families. They measured documented cancer incidence rather than cancer mortality
Incidence rates in AT relatives were significantly elevated over those in spouse controls
Breast cancer in women was the cancer most clearly associated with heterozygosity for AT
Estimated that 8 to 18% of patients with breast cancer in the U.S. white population would be heterozygous for AT
Pippard et al (1988) confirmed this observation
Excess of breast cancer deaths in British mothers of AT patients
Most frequent cancer site in the blood relatives was the female breast
Estimated risk of cancer of all types among heterozygotes as compared with noncarriers was 3.8 in men and 3.5 in women
Genes responsible for most cases of AT are located on 11q
Athma et al (1996) determined the AT gene carrier status blood relatives
33 women with breast cancer who could be genotyped; 25 of these were AT heterozygotes, compared to an expected 14.9
Athma et al (1996) estimated that, of all breast cancers in the U.S., 6.6% may occur in women who are AT heterozygotes.
NINDS Ataxia Telangiectasia Information Page
National Institute of Neurological Disorders and Stroke, June 1, 2007
"... very brief but it gives a basic understanding of A-T ..."
Ataxia Telangiectasia: Fact Sheet
National Cancer Institute, January 26, 2006
"... very concise overview of A-T ... helpful for families ..."
Ataxia-Telangiectasia Society
"... resource for families ..."
Ataxia - Telangiectasia Mutation Database
Patrick Concannon, May 18, 2007
[for Professionals mainly]
National Ataxia Foundation [USA]
[Support Group]
Established in 1957
An estimated 150,000 people in the United States are affected.
Questions and Answers: Ataxia Telangiectasia
National Institutes of Health
Ataxia telangiectasia (A-T) is a rare, recessive genetic disorder of childhood that occurs in about 1/40,000 and 1/100,000 persons worldwide. The ailment is progressive.
A-T Children's Project
Created to provide physicians, research scientists, families and support providers with information
What is A-T?
Ataxia - Telangiectasia
I.B.I.S. Birth Defects, May 8, 2003
[Ukrainian]
A fact sheet for parents in Ukrainian
What is ataxia - telangiectasia ... Symptoms and features of the disease ... Prevalence ... Prognosis ... Connection to other diseases ... Inheritance ... Diagnosis ...
________________________________________________________________________________________________
Last Updated: 2007/08/30
________________________________________________________________________________________________
|